MKKGY - Merck KGaA (MKGAF) Q4 2023 Earnings Call Transcript
2024-03-07 12:02:03 ET
Merck KGaA (MKGAF)
Q4 2023 Results Conference Call
March 7, 2024 08:00 AM ET
Company Participants
Constantin Fest - Head of Investor Relations
Belen Garijo - Chair & CEO
Helene von Roeder - CFO
Matthias Heinzel - CEO, Life Science Sector
Peter Guenter - CEO, Healthcare Business
Kai Beckmann - CEO, Electronics
Conference Call Participants
Colin White - UBS
Sophia Gray - JPMorgan
Charlie Hayward - Bank of America
Falko Friedrichs - Deutsche Bank
Gary Steventon - BNP Paribas, Exane
Edward Hall - Stifel
Oliver Metzger - ODDO BHF
Presentation
Operator
Dear ladies and gentlemen, welcome to the Merck Investor and Analyst Conference Call on the Fourth Quarter 2023. As a reminder, all participants will be in a listen-only mode.
I’m now handing over to Constantin Fest, Head of Investor Relations. He will lead you through this conference. Please go ahead, sir.
Constantin Fest
Thank you very much, Heidi. And a very warm welcome to this Merck full year '23 results call. My name is Constantin Fest, I'm the Head of Investor Relations here at Merck. And I'm delighted to be joined today by Belen Garijo, CEO of the Group, as well as Helene von Roeder, CFO of Group. Also for the Q&A part of this call we will be joining by Matthias Heinzel, CEO, Life Science; Peter Guenter, CEO, Healthcare; as well as Kai Beckmann, CEO of Electronics.
In the next couple of minutes, we would like to guide you through the key slides of this presentation, and after that we are happy to take all of your questions in the Q&A.
With this, I'd like to directly hand over to Belen to kick off the presentation. Over to you.
Belen Garijo
Thank you, Constantin, and welcome, everybody, to our full year 2023 earnings call. I'm on Slide number 5 of the presentation and would like to start with some key messages for 2023.
First of all, we have landed as expected and delivered on our guidance. Not only that, but we have also delivered to market expectations for fiscal year 2023. I hope you will agree with me that we were confronted with major market headwinds and have operated our business in a very, very challenging environment. In that context, we have shown great resilience with a strong support from our multi-industry business models....
Merck KGaA (MKGAF) Q4 2023 Earnings Call Transcript